Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia is a type of hair loss that usually happens after menopause.

A woman's skin darkened after using dutasteride and pimecrolimus for hair loss, but improved when she stopped the medications and protected her skin from light.

Menopause worsens skin, hair, and nails, affecting self-esteem and quality of life.

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

Upper eyelid hyperpigmentation can help diagnose facial lichen planus pigmentosus in patients with frontal fibrosing alopecia.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

A woman's pelvic pain and bleeding led to finding and successfully treating a rare benign tumor in her reproductive system.

Hydroxychloroquine effectively reduces symptoms of frontal fibrosing alopecia, especially in the first 6 months.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

The study found that Frontal Fibrosing Alopecia affects a broader age range of women and early treatment can help stop hair loss.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

Finasteride helps hair regrowth in frontal fibrosing alopecia.

Topical estrogen helps hair growth in menopausal women with no major side effects.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

Frontal fibrosing alopecia can affect men's beards and leads to permanent hair loss.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.